Endeavor
56 article(s) found
FDA Set to Approve Earlier Use of CAR T for Multiple Myeloma
Is Outpatient CAR T Therapy Safe for Multiple Myeloma Patients?
CAR T Effective as First-Line Therapy for High-Risk Lymphoma Patients
Identifying Inflammatory Markers Related to Toxicities Early Can Improve Multiple Myeloma Treatment
FDA Investigating ‘Serious Risk’ of Malignancy After CAR T Therapy
Patient Marks Moffitt’s 1,000th CAR T Treatment
Cell Therapy Superior to Standard of Care for Multiple Myeloma
Top 5 Moffitt Research Stories of 2022
Top 10 Moffitt Stories of 2022